Skip to main content
. 2011 Jul 1;8(5):406–412. doi: 10.7150/ijms.8.406

Table 1.

Effect of bolus injection of 5-fluorouracil (5-FU) on the plasma concentration of 5-FU (ng/mL) in the CPT-11 + 5-FU/LV + UFT/LV chemotherapy a)

Time (hr) 5-FU dosing with bolus injection of 5-FU (N = 5) without bolus injection of 5-FU (N = 5) P
0 1st oral UFT/LV 0.0±0.0 0.0±0.0 NS
0.5 14.0±31.2 1.5±3.4 NS
1 37.0±48.9 19.8±18.7 NS
2 28.5±18.7 79.3±64.7 NS
2.5 bolus injection b) 81751.0±49135.1 67.3±45.2 <0.05
2.75 21161.2±4592.7 41.4±36.9 <0.05
3 9326.7±2085.7 22.4±20.7 <0.05
3.5 1845.7±1308.2 14.0±7.6 <0.05
4 485.4±229.3 11.0±6.4 <0.05
8 2nd oral UFT/LV 25.5±10.9 5.7±6.6 <0.05
10 39.5±14.3 22.4±17.3 NS
24 4th oral UFT/LV 27.4±12.0 9.4±8.0 <0.05
48 7th oral UFT/LV 31.3±11.5 10.4±8.4 <0.05
336 15.8±11.9 0.0±0.0 <0.05

The values are the mean±SD.

a) Protocol is indicated in Figure 1. “Time 0” means 9:00 on day 1, the time of the first oral administration of UFT/LV at 100 mg x 3 as tegafur/m2/day and 25 mg x 3/day, respectively. The intravenous infusion of CPT-11 at 100 mg/m2 was done from Time = 0.5 hr to 2 hr, and followed by the infusion of l-LV at 15 mg/m2 for 30 min. Immediately thereafter, a bolus of 5-FU was injected at a dose of 500 mg/m2.

b) Five of 10 patients were not injected with a bolus of 5-FU.